the dmek triple: are we any closer to emmetropia? christopher s. sales, md, mph ; mark a. terry, md;...

12
The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII, 2015 Portland, OR Devers Eye Institute D The authors have no pertinent financial conflicts of interest to disclose.

Upload: moris-horton

Post on 22-Dec-2015

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

The DMEK Triple:Are We Any Closer to Emmetropia?

Christopher S. Sales, MD, MPH;

Mark A. Terry, MD; Zachary M. Mayko, MS;

Michael D. Straiko, MD

WCCVII, 2015

Portland, ORDeversEye InstituteD

The authors have no pertinent financial conflicts of interest to disclose.

Page 2: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

• We previously reported superior refractive predictability with the DLEK Triple compared to the PK Triple

• And even better refractive predictability with the DSAEK Triple

Background

Page 3: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Purpose

• To determine whether the new DMEK Triple delivers predictable refractive outcomes compared to our previously reported results with the DSAEK Triple.

Page 4: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Study Design

100 ConsecutiveDMEK Cases for Fuch’s

43 DMEK only57 Triple

Procedures

6 eyes excluded for factors confounding

visual acuity

51 Standard Cases

16 eyes excluded for myopic refractive

targets or unavailable 6-month data

35 eyes with 6-month follow-up and emmetropic

refractive targets

Page 5: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Study Design

Devers Standardized DMEK technique• Pre-stripped tissue from the Lions VisionGift• S-Stamp• Overstripping of the recipient• Straiko glass injector• No-touch tap technique (DMEK “Dance”)• 20% SF6 bubble

Page 6: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Study Design

• Emmetropia was targeted by selecting IOLs for a -0.70 D SE to account for the the hyperopic shift after DMEK

• Biometry was performed with the LenStar• BSCVA was measured with a Snellen

projector system

Page 7: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Study Design

Primary Outcome Measures:• Manifest refraction

Secondary Outcome Measures:• CCT• BSCVA

Page 8: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Results

Pre-Op 6 months400

450

500

550

600

650

604

524

Central Corneal Thickness After DMEK Triple

MIc

rons

* P <0.001

*

Page 9: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Results

0

0.1

0.2

0.3

0.4

0.5

BSCVA After DMEK vs. DSAEK Triple

DSAEKDMEK

logM

AR

Pre-Op POM 6

20/52n=122

20/36n=35

20/24n=35

20/31n=122

*

** P <0.001

Page 10: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Results

-1.25 -1 -0.75 -0.5 -0.25 0 0.25 0.5 0.75 1 1.25

0.11 ± 1.08 D(Range: -2.38 to

+5.00)

-0.28 ± 0.71 D(Range: -1.63 to

+1.25)Median: -0.50 D

SE 6-months After DMEK vs. DSAEK Triple

DMEK

DSAEK

Page 11: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Results

< 1 D of Emmetropia0%

10%20%30%40%50%60%70%80%90%

100%

56%

74%

89%

Frequency of SE within < 1 D of of Emmetropia After DLEK vs. DSAEK vs. DMEK Triple

DLEK, 12 mo DSAEK, 12 mo DMEK, 6 mo

Page 12: The DMEK Triple: Are We Any Closer to Emmetropia? Christopher S. Sales, MD, MPH ; Mark A. Terry, MD; Zachary M. Mayko, MS; Michael D. Straiko, MD WCCVII,

Conclusions

• The DMEK Triple delivers a greater frequency of refractive outcomes within < 1 D of emmetropia than the DSAEK Triple

• This may be because DMEK achieves a more anatomic CCT and posterior corneal curvature

• Selecting IOL targets that account for anticipated shifts in CCT and corneal curvature might further optimize refractive predictability